PreDxion Bio
closedPreDxion Bio aims to revolutionize critical care medicine by providing ICU doctors with actionable patient immune function data.
Launch date
Employees
Market cap
-
Enterprise valuation
€23—34m (Dealroom.co estimates Sep 2020.)
San Francisco California (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
- | N/A | - | |
N/A | Grant | ||
N/A | Seed | ||
N/A | $6.3m | Seed | |
Total Funding | €5.7m |
Related Content
Recent News about PreDxion Bio
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.